Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Weingrill, E; Wölfler, A; Strunk, D; Linkesch, W; Sill, H; Liebmann, PM.
Roscovitine in B-chronic lymphocytic leukemia cells: high apoptosis-inducing efficacy and synergism with alemtuzumab independent of the patients' pretreatment status.
Haematologica. 2007; 92(9): 1286-1288.
Doi: 10.3324/haematol.10680
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Führende Autor*innen der Med Uni Graz
-
Liebmann-Holzmann Peter
- Co-Autor*innen der Med Uni Graz
-
Linkesch Werner
-
Sill Heinz
-
Strunk Dirk
-
Wölfler Albert
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Roscovitine induced apoptosis in isolated B-chronic lymphocytic leukemia cells of 25 patients of whom nine with relapsed and seven with fludarabine-refractory disease. It was synergistic with alemtuzumab and restored sensitivity to alemtuzumab in initially alemtuzumab-resistant samples. Observed roscovitine-induced up-regulation of CD52 surface expression may be one of the underlying mechanisms for this synergism.
- Find related publications in this database (using NLM MeSH Indexing)
-
Aged -
-
Aged, 80 and over -
-
Antibodies, Monoclonal - administration and dosage
-
Antibodies, Neoplasm - administration and dosage
-
Antigens, CD - metabolism
-
Antigens, Neoplasm - metabolism
-
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
-
Apoptosis - drug effects
-
Cohort Studies - drug effects
-
Drug Synergism - drug effects
-
Female - drug effects
-
Glycoproteins - metabolism
-
Humans - metabolism
-
Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy
-
Male - drug therapy
-
Middle Aged - drug therapy
-
Mitoxantrone - administration and dosage
-
Purines - administration and dosage
-
Salvage Therapy - administration and dosage
- Find related publications in this database (Keywords)
-
B-CLL
-
roscovitine
-
alemtuzumab
-
apoptosis
-
synergism